Clinical Trial Update: Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing an early time-restricted eating Mediterranean diet to naltrexone/bupropion for liver fibrosis in adults with cardiometabolic ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension
• Liver Fibrosis
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Contrave (naltrexone/bupropion) (naltrexone/bupropion)

Snippet

Sponsor: Carmen Dietvorst | Conditions: Diabetes Mellitus, Type 2, Liver Fibrosis | Phase 4 | Status: ENROLLING_BY_INVITATION